Enhancing the Lucentis (Ranibizumab) Management of Choroidal Neovascular Membranes With Hyperspectral Imaging
Clinical trial NCT03105609 · TERMINATED
Trial details
- NCT number
- NCT03105609
- Sponsor
- Center for Eye Research Australia
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2017-11-14
- Primary completion
- 2018-12-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.